EPOR and ovarian carcinoma: In addition, after the downregulation of EPOR, both phosphorylated EPOR and STAT5 levels significantly decreased and either pAKT in ovarian carcinoma cells or pERK1/2 in human renal carcinoma cells were increased as a compensatory mechanism [114,115].